Cilostazol, the active ingredient in Pletal, poses potential risks during pregnancy and breastfeeding. Therefore, avoid Pletal unless explicitly recommended by your doctor.
Pregnancy: Studies haven’t fully established Cilostazol’s safety in pregnant women. Potential risks to the developing fetus exist. Your doctor will weigh the potential benefits against these risks before prescribing Pletal during pregnancy.
- Discuss all medications, including Pletal, with your doctor before conceiving or if you become pregnant. Alternative treatments are usually preferred during pregnancy.
Breastfeeding: Limited data exists on Cilostazol’s excretion in breast milk. While small amounts may transfer, the potential impact on the nursing infant isn’t fully understood. Consult your doctor to determine the best course of action for you and your baby.
- Weigh the benefits of breastfeeding against potential risks to your baby. Your physician can help you assess individual risks and benefits. Alternative pain management options may be explored during breastfeeding.
Always consult your doctor or other qualified healthcare professional before making any decisions regarding Pletal use during pregnancy or breastfeeding. They can provide personalized advice based on your specific medical history and circumstances.
